Emigrant Capital

Emigrant Capital Corp. is a private equity firm based in New York, specializing in investments in middle-market companies. As the private equity arm of Emigrant Savings Bank, it focuses on various investment strategies, including recapitalization, management buyouts, corporate acquisitions, and investments in distressed or turnaround situations. The firm primarily targets environmental products and services, software, outsourced business services, geriatric healthcare, light manufacturing, and scalable business services. Emigrant Capital typically invests between $5 million and $25 million in companies with revenues ranging from $15 million to $100 million and EBITDA between $2 million and $12 million. It employs a range of investment structures, including traditional equity, hybrid debt/equity securities, mezzanine financing, and various forms of debt. Founded in 1999, Emigrant Capital aims to establish majority or significant minority stakes in its investment targets and works closely with management teams to enhance value.

Jordan Campbell

Analyst

Christopher Hammond

Executive Vice President

Duncan Rogers

Associate

Rafael Romero

Principal

Chris Staudt

President

Bill Staudt

Vice Chairman

10 past transactions

Affiniti

Seed Round in 2024
Affiniti is a financial services company focused on enhancing banking infrastructure for small businesses in America. It offers a platform designed to provide industry-tailored credit solutions, including cash-back reward programs and vendor discounts, aimed at improving financial management. The platform enables businesses to control user permissions and manage spending limits, fostering accountability through the tracking of expenses, memos, and receipts. By catering to the specific needs of various industries, Affiniti supports small businesses in optimizing their financial operations and maximizing their savings.

Frequency Therapeutics

Series B in 2019
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to repairing or reversing damage caused by degenerative diseases through its innovative Progenitor Cell Activation approach. This method utilizes a combination of small molecules to activate progenitor cells in the body, which facilitates the creation of functional tissue without the complexities of genetic engineering. The company’s lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at treating the underlying causes of sensorineural hearing loss. In addition to FX-322, Frequency Therapeutics is exploring treatments for various degenerative conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. Established in 2014 and based in Woburn, Massachusetts, Frequency Therapeutics has established a collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322.

Golf

Acquisition in 2018
Golf.com, LLC is a prominent online platform dedicated to serving the golf community by providing comprehensive coverage of major golf tours, including the PGA, LPGA, Champions', and Nationwide tours. The platform features live leaderboard results, news, and unique commentary, catering to both professional and recreational golfers. It also offers innovative services such as Play With The Pros, an artificial intelligence technology that connects golfers with instructors for personalized swing analysis and instruction. Additionally, Golf.com provides a fee-based membership program that allows golfers to establish and maintain a USGA Handicap Index while tracking their performance. Based in Raleigh, North Carolina, Golf.com is recognized for its commitment to enhancing the golf experience through informative content and community engagement.

Frequency Therapeutics

Series A in 2017
Frequency Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to repairing or reversing damage caused by degenerative diseases through its innovative Progenitor Cell Activation approach. This method utilizes a combination of small molecules to activate progenitor cells in the body, which facilitates the creation of functional tissue without the complexities of genetic engineering. The company’s lead product candidate, FX-322, is currently undergoing phase 2a clinical trials aimed at treating the underlying causes of sensorineural hearing loss. In addition to FX-322, Frequency Therapeutics is exploring treatments for various degenerative conditions, including multiple sclerosis and diseases affecting muscle, the gastrointestinal tract, skin, and bone. Established in 2014 and based in Woburn, Massachusetts, Frequency Therapeutics has established a collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322.

GroundLink

Series A in 2008
GroundLink is a car booking platform that offers innovative transportation solutions across the United States and in over 110 countries. The company specializes in providing executive car services through a user-friendly technology platform, allowing both consumers and corporate clients to easily book rides online, via mobile apps, or by phone. GroundLink ensures timely arrivals with a guarantee that if a driver is late, the next ride is free. Users can track their drivers in real-time and receive electronic receipts directly to their inboxes, eliminating the need for paper vouchers. With a focus on convenience and reliability, GroundLink aims to redefine the car service experience for its customers.

Lev Pharmaceuticals

Venture Round in 2006
Lev Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on developing and commercializing therapeutic products for the treatment of inflammatory diseases. Its products include C1-INH that is used for the treatment of hereditary angioedema. The company was founded in 2003 and is based in New York, New York. As of October 21, 2008, Lev Pharmaceuticals, Inc. operates as a subsidiary of ViroPharma Inc.

Global Learning Systems

Seed Round in 2006
Global Learning Systems, LLC is a provider of cybersecurity awareness training and e-learning solutions, established in 2006 and headquartered in Clarksville, Maryland, with an additional office in Lynchburg, Virginia. The company specializes in creating tailored training programs designed to enhance security awareness and resilience within organizations, offering products such as the Human Firewall 2.0 training program and a variety of tools, including phishing simulations and courseware customization. Global Learning Systems serves a diverse clientele, including enterprises, small and medium businesses, educational institutions, and government organizations, delivering its services in over 25 languages. The company's approach focuses on integrating technology with training to develop human capital resources and address business challenges effectively. Global Learning Systems operates as a subsidiary of Bancroft Technology Group Inc.

Boylan Bottling

Venture Round in 2003
Boylan Bottling Co., Inc. is a producer of hand-crafted sodas, established in 1891 and based in Moonachie, New Jersey. The company specializes in a variety of flavors, including ginger ale, root beer, black cherry, creme soda, cane cola, orange, and grape. In addition to traditional cane sugar sodas, Boylan Bottling also offers diet versions of some of its popular flavors. The company markets its products through retailers and online platforms, providing a range of beverages that cater to diverse consumer preferences.

Intralinks

Venture Round in 2001
Intralinks Holdings, Inc. is a technology company that specializes in software-as-a-service (SaaS) solutions for secure enterprise content collaboration, both domestically and internationally. Founded in 1996 and based in New York, Intralinks provides a cloud-based platform that facilitates the management, control, and exchange of sensitive information within and between organizations. Its product offerings include Intralinks Dealspace for virtual deal rooms, Intralinks Studyspace for sharing confidential information, and Intralinks VIA for enterprise content sharing. The company serves a diverse range of industries, including financial services, life sciences, technology, and manufacturing, and caters to enterprises, financial institutions, and governmental agencies. Intralinks distributes its solutions directly through a dedicated sales team and indirectly via a network of channel partners and customer referrals. The company has undergone several changes in ownership and name, most recently becoming a subsidiary of SS&C Technologies Holdings, Inc.

RealNames

Series D in 2000
RealNames is an online platform founded in 1996 by Keith Teare, headquartered in San Carlos, California, with additional offices in New York City, London, Hamburg, Tokyo, and Seoul. The company specializes in providing email naming solutions and a navigation system designed to simplify internet use. Its flagship offering is the RealNames system, which allows users to navigate the web using keywords instead of traditional URLs, enhancing the browsing experience. RealNames' products cater to a diverse clientele, including companies of various sizes, advertising agencies, internet service providers, online services, search engines, and directory services. The platform also features an ad-free email solution compatible with popular email programs as well as web and mobile applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.